CEL-SCI Corp - Asset Resilience Ratio

Latest as of December 2025: 27.45%

CEL-SCI Corp (CVM) has an Asset Resilience Ratio of 27.45% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read CEL-SCI Corp (CVM) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

$6.28 Million

Cash + Short-term Investments

Total Assets

$22.89 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (1999–2025)

This chart shows how CEL-SCI Corp's Asset Resilience Ratio has changed over time. See shareholders equity of CEL-SCI Corp for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down CEL-SCI Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CEL-SCI Corp (CVM) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$6.28 Million	27.42%
Short-term Investments	$7.09K	0.03%
Total Liquid Assets	$6.28 Million	27.45%

Asset Resilience Insights

Very High Liquidity: CEL-SCI Corp maintains exceptional liquid asset reserves at 27.45% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

CEL-SCI Corp Industry Peers by Asset Resilience Ratio

Compare CEL-SCI Corp's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Sagimet Biosciences Inc. Series A Common Stock NASDAQ:SGMT	Biotechnology	63.03%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	43.36%
Inner Mongolia Furui Med Sci SHE:300049	Biotechnology	2.34%
Bio-Thera Solutions Ltd SHG:688177	Biotechnology	4.09%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Gubra A/S CO:GUBRA	Biotechnology	79.61%

Annual Asset Resilience Ratio for CEL-SCI Corp (1999–2025)

The table below shows the annual Asset Resilience Ratio data for CEL-SCI Corp.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-09-30	38.93%	$10.96 Million	$28.16 Million	+21.36pp
2024-09-30	17.57%	$4.74 Million	$26.99 Million	+3.99pp
2023-09-30	13.58%	$4.15 Million	$30.53 Million	-31.29pp
2022-09-30	44.87%	$22.67 Million	$50.52 Million	-10.76pp
2021-09-30	55.64%	$42.21 Million	$75.87 Million	+17.38pp
2020-09-30	38.26%	$15.51 Million	$40.54 Million	+7.69pp
2019-09-30	30.57%	$8.44 Million	$27.62 Million	-4.28pp
2018-09-30	34.85%	$10.31 Million	$29.59 Million	+24.51pp
2017-09-30	10.34%	$2.37 Million	$22.92 Million	-16.16pp
2016-09-30	26.50%	$3.07 Million	$11.60 Million	--
2015-09-30	0.00%	$0.00	$15.45 Million	--
2014-09-30	0.00%	$0.00	$19.23 Million	--
2013-09-30	0.00%	$0.00	$10.84 Million	--
2012-09-30	0.00%	$0.00	$16.07 Million	--
2011-09-30	0.00%	$0.00	$18.63 Million	--
2009-09-30	3.44%	$1.59 Million	$46.03 Million	+2.08pp
2008-09-30	1.36%	$200.00K	$14.68 Million	-11.80pp
2001-09-30	13.16%	$593.38K	$4.51 Million	-14.08pp
2000-09-30	27.24%	$3.76 Million	$13.81 Million	-14.87pp
1999-09-30	42.11%	$3.20 Million	$7.60 Million	--

pp = percentage points

About CEL-SCI Corp

NYSE MKT:CVM USA Biotechnology

Market Cap

$12.26 Million

Market Cap Rank

#26520 Global

#5395 in USA

Share Price

$1.45

Change (1 day)

-8.81%

52-Week Range

$1.19 - $13.04

All Time High

$27.64